Gadolinium has been found in the brain, skin and bone of patients with normal renal function months to years after the last administration of a gadolinium-based contrast agent (GBCA). Yttrium (Y3+) has similar size and chemical properties to Gd3+. We investigated whether yttrium can be used as a gadolinium surrogate by measuring the biodistribution of Gd-DTPA/Y-DTPA and Gd-DOTA/Y-DOTA (0.6 mmol/kg) in mice. Residual Gd and Y levels 7 days after injection showed a Y:Gd ratio close to 1 in all organs demonstrating that Y can act as a surrogate for Gd.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords